問卷
Log In
繁中 EN
TPIDB
TPIDB Outstanding PI
TPIDB > Study Site

Study Site



CHANGHUA CHRISTIAN HOSPITAL

  • 0

    Total Beds

  • 0

    Total Doctors

  • 500Changhua CountyChanghua Changhua

Recruiting Trial

278Cases

篩選

Developmental Phase

  • Phase I

  • Phase I/II

  • Phase II

  • Phase II/III

  • Phase III

  • Phase IV

  • Others

Trial Status

  • Not yet recruiting

  • Active

  • Completed

Recruitment Status

  • Not yet recruiting

  • Recruiting

  • Completed

  • Terminated

  • Stop recruiting

  • Suspended

  • Study ended

Trial scale

  • Multi-Regional Multi-Center

  • Taiwan Multiple Center

  • Taiwan Single Center

The expected start time interval of the test

-

Trial Applicant

  • Hospital/Foundation

  • Pharmaceutical/Biopharmaceutical company

  • Contract Research Organization

Important Roles

  • Asia Regional PI

  • Taiwan National PI

  • Chairman/Global PI

  • Steering Committee

  • Advisory board

  • None

Audit by Sponsors/CRO

  • Sponsors

  • CRO

  • None

Investigator-initiated trial(IIT)

  • Yes

Filters

List

789Cases

2020-10-01 - 2026-12-31

Phase III

Active
-

  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
8Sites

Not yet recruiting7Sites

Recruiting1Sites

2020-10-15 - 2027-09-01

Phase III

Active
-

  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
13Sites

Recruiting13Sites

2020-11-06 - 2023-12-26

Phase II

Completed
-

  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
7Sites

Not yet recruiting2Sites

Recruiting5Sites

2020-12-14 - 2024-03-31

Phase III

Active
-

  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
8Sites

Recruiting8Sites

2021-01-01 - 2029-07-31

Phase III

Active
-

  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
8Sites

Recruiting8Sites

2021-01-01 - 2024-12-31

Phase III

Completed
-

  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
7Sites

Recruiting6Sites

Terminated1Sites

2021-01-04 - 2026-03-31

Others

Completed
-

  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
6Sites

Terminated6Sites

2021-03-01 - 2026-12-31

Phase III

Active
-

  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
5Sites

Not yet recruiting3Sites

Recruiting2Sites

2021-04-26 - 2024-07-22

Phase III

Completed
-

  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
6Sites

Not yet recruiting2Sites

Recruiting4Sites

2026-06-01 - 2032-12-31

Phase III

Not yet recruiting
A phase 3, randomized, multicenter, open-label trial comparing velzatinib (GSK6042981) with imatinib in participants with previously untreated metastatic and/or unresectable gastrointestinal stromal tumors (GIST).

  • Condition/Disease

    Previously untreated metastatic and/or unresectable gastrointestinal stromal tumors

  • Test Drug

    Imatinib tablets 100mg Imatinib tablets 400mg Velzatinib (GSK6042981) Tablets 100mg

Participate Sites
5Sites

Not yet recruiting1Sites

1 2 3 4 5 79
聯絡我們

台灣臨床試驗主持人資料庫 TPIDB

All Contents Copyright 2020 台灣臨床試驗主持人資料庫TPIDB